Double Trouble

Dual primary malignancies are more common than previously thought, but management is complex and research is limited. When Rouslan Kotchetkov, MD, PhD, a hematologist/oncologist at Simcoe Muskoka Regional Cancer Centre in Ontario, Canada, started practicing...

Online Exclusives

New Medicare Legislation Aims to Accelerate Coverage of Medical Devices, Make...

New legislation building on the 21st Century Cures Act of 2016 would accelerate coverage of medical devices under Medicare. It would also permanently remove...

U.S. Insurers Asked to Report Prescription Drug Cost Data to Federal...

An interim final rule issued by the Biden administration will require private insurers to report prescription drug costs to the U.S. federal government. Under the...

News

From the Blood Journals

WIB_icon

Adding All-Trans Retinoic Acid to Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed...

A combination regimen comprising all-trans retinoic acid (ATRA) plus low-dose rituximab was associated with an 80% overall response rate and a 61% sustained response...
WIB_icon

Liso-Cel Shows Promising Safety and Efficacy in Relapsed/Refractory CLL/SLL

In patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), treatment with lisocabtagene maraleucel (liso-cel) was associated with deep, rapid responses...

Multimedia

Kathi Mooney: Impact of Remote Monitoring on Patients with Cancer During...

Remote monitoring and treatment of cancer and treatment-related symptoms during the COVID-19 pandemic was associated with significant reductions in symptom burden and improvements in...

Ann LaCasce: PET Adapted Therapy Allows Omission of Radiation Therapy in...

Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology’s CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.

Paolo Ghia: Ibrutinib Plus Venetoclax Produces Deep Responses in Patients with...

Here, Paolo Ghia, MD, PhD, of Vita-Salute San Raffaele University in Milan, Italy, discusses recent findings from the phase II CAPTIVATE study evaluating fixed-duration...

Vincent Wagner and Ellen Marcus: Use of the Khorana Score to...

Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.

On Location

On location

Pilot Study Finds Remote Monitoring of Patients Undergoing Chemotherapy Feasible

Using technology to monitor outpatients undergoing cancer treatments at home was feasible and led to...
On location

A New Clinical Ladder for Advanced Practitioners Improves Retention, Engagement

Five years after implementing a “clinical ladder” for advanced practitioners (APs), Moffitt Cancer Center reports...
On location

Amino Acids Could Reduce Cancer Treatment–Related Diarrhea

Treatment-related diarrhea is a common adverse event (AE) associated with cancer-directed therapies, negatively affecting patients’...

HPSCs and Hematopoiesis: From Development to Stem Cell Therapies

As part of this year’s Scientific Program, Gay M. Crooks, MBBS, and Christopher M. Sturgeon,...

The Future of Iron Therapeutics

Therapies for disorders of iron metabolism are rapidly progressing beyond venesection, chelation, and nutritional iron...

Blood and Beyond: Irrigating the Clinical Desert

This year’s Blood and Beyond session will be hosted by Nancy Berliner, MD, Editor-in-Chief of Blood,...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Congratulates Three New ASH Executive Committee Members, and more

Congratulations to Three New ASH Executive Committee Members! The American Society of Hematology (ASH) has announced the election of three new members to its Executive...
ASH Directions

ASH Releases Clinical Practice Guidelines on Stem Cell Transplantation in SCD, Honors Donna S....

NEW! ASH Clinical Practice Guidelines on Stem Cell Transplantation in Sickle Cell Disease The American Society of Hematology (ASH) has published clinical practice guidelines on...

Sign up for our
eNewsletter!

The Society Pages

ASH Remembers Joseph Bertino, National Academy of Medicine Elects Helen Heslop, and more

Remembering Joseph Bertino (1930 – 2021) Pioneering oncologist Joseph R. Bertino, MD, died on October 11, 2021, at the age of 91.In 1961, Dr. Bertino...
The Society Pages

Remembering Elihu “Eli” Estey, Thomas Waldmann, and more

Remembering Elihu (Eli) Estey (1946 - 2021) Renowned hematologist Elihu (Eli) Estey, MD, died suddenly on October 11, 2021, at the age of 75.After completing...
The Society Pages

NCI Grants $1.8M for Cancer Genome Atlas Research, Sarah Cannon Names Navneet Majhail Physician-in-Chief...

Sarah Cannon Appoints Navneet Majhail as Deputy Physician-in-Chief of Blood Cancers Sarah Cannon Research Institute has named Navneet Majhail, MD, deputy physician-in-chief of blood cancers...

Double Trouble

Dual primary malignancies are more common than previously thought, but management is complex and research is limited. When Rouslan Kotchetkov, MD, PhD, a hematologist/oncologist at...

Crossing the Doctor Desert

Hematologists and oncologists are turning to new delivery models and telemedicine to chart a path through these medically underserved areas Rural Americans make up an...

The National Cancer Act Turns 50

The National Cancer Act of 1971 set the stage for coordination of research across the U.S. and progress that continues to this day. 2021 marks...